Renal Cancer

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Serum and Tissue Samples From Biopsy-Proved or Suspected

Recruiting
  • Malignant Neoplasms
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

    Recruiting
    • ccRCC
    • +9 more
    • Oral NKT2152
    • Scottsdale, Arizona
    • +6 more
    Oct 17, 2022

    Repository for Related Biological Studies

    Recruiting
    • Sarcoma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 7, 2022

      Cervical Cancer, Renal Cancer, Urothelial Cancer Trial run by the NCI (Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood

      Completed
      • Cervical Cancer
      • +4 more
      • Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Mar 2, 2022

      Breast Cancer, Lung Cancer, Renal Cancer Trial run by the NCI (FPAC)

      Terminated
      • Breast Cancer
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 14, 2019

      Metastatic Cancer, Metastatic Melanoma, Renal Cancer Trial run by the NCI (Anti-VEGFR2 CAR CD8 plus PBL, Cyclophosphamide,

      Terminated
      • Metastatic Cancer
      • +2 more
      • Anti-VEGFR2 CAR CD8 plus PBL
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Nov 18, 2019

      Breast Cancer, Cervical Cancer, Renal Cancer Trial run by the NCI (Aldesleukin, Fludarabine, Cyclophosphamide)

      Terminated
      • Breast Cancer
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jun 4, 2019

      Renal Cancer, Kidney Cancer Trial run by the NCI (2G-1 TCR Retroviral Vector-Transduced lyn, Aldesleukin, Cyclophosphamide)

      Terminated
      • Renal Cancer
      • Kidney Cancer
      • 2G-1 TCR Retroviral Vector-Transduced lyn
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 6, 2019

      Renal Cancer, Birt-Hogg-Dube Syndrome Trial run by the NCI (Everolimus)

      Terminated
      • Renal Cancer
      • Birt-Hogg-Dube Syndrome
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Mar 7, 2019

      Renal Cancer, Von Hippel Lindau Trial run by the NCI (ZACTIMA (Vandetanib) (ZD6474))

      Completed
      • Renal Cancer
      • Von Hippel Lindau
      • ZACTIMA (Vandetanib) (ZD6474)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 2, 2018

      Renal Cancer, Kidney Cancer Trial in United States (Bevacizumab)

      Completed
      • Renal Cancer
      • Kidney Cancer
      • Fort Myers, Florida
      • +12 more
      Dec 12, 2014